{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:45:30Z","timestamp":1759041930571},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["15K08246","16K08559"],"award-info":[{"award-number":["15K08246","16K08559"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jphs.2017.08.002","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T19:31:48Z","timestamp":1502739108000},"page":"239-246","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of proarrhythmic potential of an atypical antipsychotic drug paliperidone in the halothane-anesthetized dogs"],"prefix":"10.1016","volume":"134","author":[{"given":"Koki","family":"Chiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Hagiwara-Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko T.","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2017.08.002_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2146\/ajhp070261","article-title":"Paliperidone for schizophrenia","volume":"65","author":"Dolder","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jphs.2017.08.002_bib2","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1080\/03007995.2016.1198755","article-title":"Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia","volume":"32","author":"Pierce","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jphs.2017.08.002_bib3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/FJC.0b013e318217d941","article-title":"Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?","volume":"57","author":"Vigneault","year":"2011","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jphs.2017.08.002_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/NDT.S1365","article-title":"Paliperidone ER: a review of the clinical trial data","volume":"3","author":"Janicak","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jphs.2017.08.002_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jphs.2016.05.001","article-title":"In\u00a0vivo analysis of torsadogenic potential of an antipsychotic drug paliperidone using the acute atrioventricular block rabbit as a proarrhythmia model","volume":"132","author":"Hagiwara","year":"2016","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2017.08.002_bib6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/bjp.2008.240","article-title":"Sensitive and reliable proarrhythmia in\u00a0vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts","volume":"154","author":"Sugiyama","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2017.08.002_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil","volume":"96","author":"Johannesen","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jphs.2017.08.002_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2131\/jts.41.439","article-title":"Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak\u2013Tend analysis in the halothane-anesthetizes beagle dogs","volume":"41","author":"Cao","year":"2016","journal-title":"J\u00a0Toxicol Sci"},{"key":"10.1016\/j.jphs.2017.08.002_bib9","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000145162.64183.C8","article-title":"Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs","volume":"110","author":"Thomsen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2017.08.002_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejphar.2014.06.064","article-title":"Effects of selective IKr channel blockade by E-4031 on ventricular electromechanical relationship in the halothane-anesthetized dogs","volume":"740","author":"Izumi-Nakaseko","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2017.08.002_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12012-016-9369-8","article-title":"Anti-atrial fibrillatory versus proarrhythmic potentials of amiodarone: a new protocol for safety evaluation in\u00a0vivo","volume":"17","author":"Matsukura","year":"2017","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jphs.2017.08.002_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","article-title":"An improved method to correct the QT interval of the electrocardiogram for changes in heart rate","volume":"22","author":"Van de Water","year":"1989","journal-title":"J\u00a0Pharmacol Methods"},{"key":"10.1016\/j.jphs.2017.08.002_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/taap.1998.8494","article-title":"Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring","volume":"152","author":"Sugiyama","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jphs.2017.08.002_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.301.2.427","article-title":"Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel","volume":"301","author":"Ekins","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2017.08.002_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vascn.2014.07.002","article-title":"Prediction of thorough QT study results using action potential simulations based on ion channel screens","volume":"70","author":"Mirams","year":"2014","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"key":"10.1016\/j.jphs.2017.08.002_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in\u00a0vitro and in\u00a0vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jphs.2017.08.002_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0014-2999(95)00753-9","article-title":"Negative chronotropic and dromotropic effects of E-4031, an IKr blocker, on the atrioventricular node in anesthetized dog hearts","volume":"297","author":"Yamazaki","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2017.08.002_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12012-013-9202-6","article-title":"Cardiohemodynamic and electrophysiological effects of anti-influenza drug oseltamivir in\u00a0vivo and in\u00a0vitro","volume":"13","author":"Kitahara","year":"2013","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jphs.2017.08.002_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1254\/jjp.87.74","article-title":"Acute electropharmacological effects of intravenously administered amiodarone assessed in the in\u00a0vivo canine model","volume":"87","author":"Sugiyama","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.jphs.2017.08.002_bib20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/BF02244986","article-title":"Plasma protein binding of risperidone and its distribution in blood","volume":"114","author":"Mannens","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jphs.2017.08.002_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/bdd.1801","article-title":"Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier","volume":"33","author":"Nagasaka","year":"2012","journal-title":"Biopharm Drug Dispos"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861317301135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861317301135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T14:57:20Z","timestamp":1535468240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861317301135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1347861317301135"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2017.08.002","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of proarrhythmic potential of an atypical antipsychotic drug paliperidone in the halothane-anesthetized dogs","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2017.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}